Cite

HARVARD Citation

    Çelik, S. et al. (n.d.). Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy. Leukemia research. pp. S39-. [Online]. 
  
Back to record